HTFL Share Price Performance
US$31.04
2.29 (7.97%)
19.6% undervalued intrinsic discount
US$38.60
Fair Value
Price US$31.04
AnalystConsensusTarget US$38.60
Fair ValueUS$38.60
Share Pricen/a
HeartFlow, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
HTFL Community Narratives
AN
Fair Value US$38.6 19.6% undervalued intrinsic discount
Coronary CT Adoption And AI Platform Will Support A Stronger Long Term Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Coronary CT Adoption And AI Platform Will Support A Stronger Long Term Outlook
Catalysts About HeartFlow HeartFlow provides an AI based software platform that supports detection, diagnosis, management and treatment planning for coronary artery disease using cardiac CT imaging. What are the underlying business or industry changes driving this perspective?Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$38.6
19.6% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
23.5% p.a.
Profit Margin
6.93%
Future PE
241.78x
Price in 2029
US$51.94
Trending Discussion
Recently Updated Narratives
AN
Coronary CT Adoption And AI Platform Will Support A Stronger Long Term Outlook
Fair Value: US$38.6 19.6% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
HeartFlow, Inc. Key Details
About HTFL
- Founded
- 2007
- Employees
- 699
- CEO
- WebsiteView website
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries. The company’s platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
